Carcinoma, Renal Cell D002292

Related MeSH Hierarchy (9)

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Carcinoma, Renal Cell

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Carcinoma, Renal Cell

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Carcinoma, Renal Cell

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Kidney Neoplasms » Carcinoma, Renal Cell

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Urologic Neoplasms » Kidney Neoplasms » Carcinoma, Renal Cell

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Kidney Neoplasms » Carcinoma, Renal Cell

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urologic Neoplasms » Kidney Neoplasms » Carcinoma, Renal Cell

Description

A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.   MeSH

Hierarchy View


Phase 2 Indicated Drugs (208)

Phase 1 Indicated Drugs (144)


Organization Involved with Phase 3 Indications (72)

Organization Involved with Phase 2 Indications (301)

Abbott

AbbVie

Academic and Community Cancer Research United

Acceleron Pharma, Inc.

Accelovance

Acorn Cardiovascular, Inc.

Agennix

Agensys, Inc.

AIO-Studien-gGmbH

Altor Bioscience

Antisoma Research

A.O. Melegnano - Gorgonzola

Apices Soluciones S.L.

Apollomics, Inc.

Aptose Biosciences Inc.

Aravive Biologics

ArQule

Array BioPharma

Associació per a la Recerca Oncologica, Spain

Associacio Per la Recerca Oncológica

Association of Urogenital Oncology (AUO)

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Astellas

Attenuon

Auckland District Health Board

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Azienda Ospedaliera San Gerardo di Monza

AZ Sint-Lucas

Badalona Hospital Germans Trias i Pujol

Barts & The London NHS Trust

Baylor University

BeiGene

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.

BIAFFIN GmbH & Co. KG

Big Ten Cancer Research Consortium

Bionomics Limited

Blokhin's Russian Cancer Research Center

Boehringer Ingelheim

Boston Biomedical

Brown University

Burzynski Research Institute

Caladrius Biosciences

Calithera Biosciences

Cancer Biotherapy Research Group

Cancer Treatment Centers of America

Cancer Trials Ireland

CASI Pharmaceuticals, Inc.

Celgene

Celldex Therapeutics

Centocor

Central European Society for Anticancer Drug Research (CESAR)

Central South University

Centro di Riferimento Oncologico - Aviano

Changhai Hospital

Chiles Cancer Center

China Medical University

Chinese Academy of Medical Sciences

City of Hope National Medical Center

Cleveland BioLabs

Clinical Research Technology S.r.l.

Clinica Universidad de Navarra

CoImmune

Columbia University

Cytokine Working Group

Dartmouth University

Department of Veteran Affairs

Dragonfly Therapeutics

Driven To Cure

Duke University

Dutch Cancer Society

Egyptian Foundation for Cancer Research

Eli Lilly

Emory University

Endocyte

Evelo Biosciences

Free University of Amsterdam

Fundacion Instituto Valenciano de Oncologia

General Electric

Genmab

Genocea Biosciences, Inc.

Genzyme

Ghent University

Gloucester Pharmaceuticals

Gottfried Wilhelm Leibniz Universität Hannover

Government of China

Government of France

Government of Poland

Government of Russia

Gruppo Italiano Carcinoma Renale

Guangzhou Medical University

Guangzhou University

GZA Ziekenhuizen Campus Sint-Augustinus

Harbin Medical University

HealthPartners Institute

Hebrew University

Hengrui Therapeutics, Inc.

Hestia Duran i Reynals

Hoag Memorial Hospital Presbyterian

Hoosier Cancer Research Network

Hope Cancer Institute, Inc.

Hopital Saint Andre

Hospital Son Espases

Hospital Universitario Central de Asturias

HUYA Bioscience International

Idera

IGENZ, Ltd.

Immunicum AB

Immunomedics

Infinity Pharmaceuticals, Inc.

Inova Health System

Inspyr Therapeutics, Inc.

Institut Gustave Roussy

Instituto do Cancer do Estado de São Paulo

Institut Paoli-Calmettes

Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.

Ipsen

IQVIA

Istituto Clinico Humanitas - Rozzano (MI), Italy

Istituto Nazionale per lo Studio e la Cura dei Tumori

Italian Trial in Medical Oncology

Jinan University

Johns Hopkins University

J. W. Goethe University

King Faisal Specialist Hospital

King Faisal University

Klus Pharma Inc.

Korean Urological Oncology Society

Kymab Limited

Kyungpook University

Lantheus Medical Imaging

Ligue contre le cancer, France

Loma Linda University

Lpath, Inc.

Ludwig Institute for Cancer Research

Lund University

Marche Polytechnic University

Mayo Clinic

McMaster University

Medical University of South Carolina

MedImmune

Memorial Sloan-Kettering Cancer Center

Methodist Cancer Center, Houston, Texas

Millennium Pharmaceuticals

Mirati Therapeutics Inc.

Mologen AG

Nanjing Medical University

Nanjing University

National Heart, Lung, and Blood Institute (NHLBI)

Netherlands Cancer Institute

Netherlands Working Group on Immunotherapy of Oncology

Newcastle University

NewLink Genetics Inc

New Mexico Cancer Care Alliance

New York University

Novo Nordisk

Ohio State University

OncoImmune, Inc.

Oncotech

Onyx

Optum

ORION Clinical Services

OSI Pharmaceuticals

Ospedale di Como

Ospedale di Mantova

Ospedale Fatebenefratelli di Roma

Ospedale Sacro Cuore

Ospedaliera Valtellina

Our Lady of Mercy Cancer Center

Our Lady of Mercy Medical Center

Ozmosis Research Inc.

Peloton Therapeutics, Inc.

Pennsylvania State University

People's Liberation Army of China

Peter MacCallum Cancer Centre

Pharmacyclics

Pivotal S.L.

PrECOG, LLC.

Prometheus Inc.

Providence Health & Services

Qingdao University

Quercegen Pharmaceuticals

Region Skane

Rexahn Pharmaceuticals, Inc.

Russian Academy of Medical Sciences

Rutgers University

RWTH Aachen University

Saint Francis Memorial Hospital

Sanofi

Schering-Plough

Scottish Clinical Trials Research Unit

SCRI Development Innovations

Seoul National University

Shenzhen BinDeBio Ltd.

Shenzhen Hank Bioengineering Institute

Sichuan University

Sinobioway Cell Therapy Co., Ltd.

Sirna Therapeutics

Southern China Urology Cancer Consortium

Spanish Oncology Genito-Urinary Group

Stanford University

Steba Biotech S.A.

St. Louis University

Sungkyunkwan University

Sunshine Lake Pharma Co., Ltd.

Sun Yat-Sen University

Swiss Group for Clinical Cancer Research

Symphony Capital

Syndax Pharmaceuticals

Taipei Veteran General hospital

Taiwan Liposome Company

Takeda

Technion University

Temple University

Tesaro

TFS Trial Form Support

Thallion Pharmaceuticals

The Angeles Clinic

The Christie NHS Foundation Trust

The Cleveland Clinic

Theradex

The University of Texas, Dallas

Thomas Jefferson University

Threshold Pharmaceuticals

Tianjin Medical University

Tokyo Women's Medical University

Tracon Pharmaceuticals Inc.

Trial Form Support S.L.

Tsinghua University

UNICANCER

Universidad Autonoma de Barcelona

Universidad Complutense de Madrid

University of Alberta

University of Amsterdam

University of Antwerp

University of Arizona

University of Auckland

University of Barcelona

University of Brescia

University of Calgary

University of California, Berkeley

University of California, Davis

University of California, San Diego

University of Cincinnati

University of Colorado, Denver

University of Copenhagen

University of Duisburg-Essen

University of Florida

University of Franche-Comté

University of Iowa

University of Kansas

University of Kentucky

University of Liverpool

University of Manchester

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Michigan

University of Minnesota

University of Montpellier

University of Montreal

University of Nebraska

University of New Mexico

University of Oklahoma

University of Oxford

University of Padova

University of Pavia

University of Perugia

University of Pisa

University of Pittsburgh

University of Quebec

University of Rennes

University of Siena

University of South Carolina

University of Southern California

University of South Florida

University of Texas, San Antonio

University of Toronto

University of Tuebingen

University of Turin

University of Udine

University of Ulsan

University of Utah

University of Vermont

University of Virginia

University of Washington

University of Wisconsin

Urological Institute of Northeastern New York

Utrecht University

Vanderbilt University

Vita-Salute University of Milano. Italy

Wake Forest University

Washington University in St. Louis

Wayne State University

West Virginia University

Wyeth

X4 Pharmaceuticals

Xuzhou Medical University

Yale University

Yeshiva University

Zhejiang University

Zhengzhou University

ZymoGenetics

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.